BMEA
Biomea Fusion Inc
NASDAQ: BMEA · HEALTHCARE · BIOTECHNOLOGY
$1.36
-6.21% today
Updated 2026-04-30
Market cap
$136.65M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-1.18
Dividend yield
—
52W range
$1 – $3
Volume
1.5M
Biomea Fusion Inc (BMEA) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | $-1.28M | $-4.46M | $-35.44M | $-62.42M | $-96.59M | $-119.89M | $-70.37M |
| Capital expenditures | $51000.00 | $51000.00 | $3.17M | $1.03M | $3.37M | $362000.00 | $0.00 |
| Depreciation | — | — | — | — | — | — | — |
| Stock-based comp | $0.00 | $322000.00 | $6.23M | $10.34M | $14.13M | $19.09M | $9.52M |
| Free cash flow | $-1.33M | $-4.51M | $-38.61M | $-63.45M | $-99.96M | $-120.26M | $-70.37M |
| Investing cash flow | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — |
| Net change in cash | — | — | $84.39M | $-33.84M | — | — | — |